New York Methodist Hospital to study airway bypass treatment for emphysema
Feb 6, 2008 - 12:04:37 AM
Brooklyn, NY, February 4, 2007 -- New York Methodist Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. The study focuses on a procedure called airway bypass that involves creating pathways in the lung for trapped air to escape and in turn, relieve emphysema symptoms including shortness of breath.
Emphysema is a chronic, progressive, and irreversible lung disease characterized by the destruction of lung tissue. The loss of the lungs' natural elasticity and the collapse of airways in the lung combine to make exhalation ineffective, leaving the emphysema sufferer with hyperinflation because they can't get air out of their lungs. With hyperinflation, breathing becomes inefficient and the patient is always short of breath. Even the most nominal physical activities become difficult for emphysema patients and many become dependent on oxygen therapy.
We are excited to be part of this study because currently there are limited treatment options for the emphysema patients. Patients are often in poor physical condition, struggling with each breath, states Arthur Sung, MD, Director of Interventional Pulmonology and the principal investigator of the study at NYM's Institute for Asthma and Other Lung Diseases. By creating new pathways for airflow with the airway bypass procedure, we hope to reduce hyperinflation and improve lung function. If patients can breathe easier it is likely to improve their quality of life.
All rights reserved by RxPG Medical Solutions Private Limited ( www.rxpgnews.com )